120 related articles for article (PubMed ID: 19278423)
1. The disintegrin-metalloproteinases ADAM 10, 12 and 17 are upregulated in invading peripheral tumor cells of basal cell carcinomas.
Oh ST; Schramme A; Stark A; Tilgen W; Gutwein P; Reichrath J
J Cutan Pathol; 2009 Apr; 36(4):395-401. PubMed ID: 19278423
[TBL] [Abstract][Full Text] [Related]
2. Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas.
Karan D; Lin FC; Bryan M; Ringel J; Moniaux N; Lin MF; Batra SK
Int J Oncol; 2003 Nov; 23(5):1365-71. PubMed ID: 14532978
[TBL] [Abstract][Full Text] [Related]
3. Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma.
Oh ST; Kim HS; Yoo NJ; Lee WS; Cho BK; Reichrath J
Br J Dermatol; 2011 Dec; 165(6):1197-204. PubMed ID: 21729023
[TBL] [Abstract][Full Text] [Related]
4. Characterization of matrix metalloproteinase-2 and -9, ADAM-10 and N-cadherin expression in human glioblastoma multiforme.
Musumeci G; Magro G; Cardile V; Coco M; Marzagalli R; Castrogiovanni P; Imbesi R; Graziano AC; Barone F; Di Rosa M; Castorina S; Castorina A
Cell Tissue Res; 2015 Oct; 362(1):45-60. PubMed ID: 25948484
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of ADAM family members in human breast cancer and breast cancer cell lines.
Lendeckel U; Kohl J; Arndt M; Carl-McGrath S; Donat H; Röcken C
J Cancer Res Clin Oncol; 2005 Jan; 131(1):41-8. PubMed ID: 15565459
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of ADAM (a disintegrin and metalloproteinase) genes between human first trimester villous and extravillous trophoblast cells.
Takahashi H; Yuge K; Matsubara S; Ohkuchi A; Kuwata T; Usui R; Suzuki M; Takizawa T
J Nippon Med Sch; 2014; 81(3):122-9. PubMed ID: 24998958
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy.
Fedak PW; Moravec CS; McCarthy PM; Altamentova SM; Wong AP; Skrtic M; Verma S; Weisel RD; Li RK
Circulation; 2006 Jan; 113(2):238-45. PubMed ID: 16401770
[TBL] [Abstract][Full Text] [Related]
8. ADAM10 is the constitutive functional sheddase of CD44 in human melanoma cells.
Anderegg U; Eichenberg T; Parthaune T; Haiduk C; Saalbach A; Milkova L; Ludwig A; Grosche J; Averbeck M; Gebhardt C; Voelcker V; Sleeman JP; Simon JC
J Invest Dermatol; 2009 Jun; 129(6):1471-82. PubMed ID: 18971959
[TBL] [Abstract][Full Text] [Related]
9. ADAM-10 and ADAM-17 in the inflamed human CNS.
Kieseier BC; Pischel H; Neuen-Jacob E; Tourtellotte WW; Hartung HP
Glia; 2003 Jun; 42(4):398-405. PubMed ID: 12730960
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of ADAM 10 and ADAM 12 in lesional psoriatic skin.
Oh ST; Schramme A; Stark A; Tilgen W; Gutwein P; Reichrath J
Br J Dermatol; 2008 Jun; 158(6):1371-3. PubMed ID: 18363768
[No Abstract] [Full Text] [Related]
11. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
12. Expression of members of a novel membrane linked metalloproteinase family (ADAM) in human articular chondrocytes.
McKie N; Edwards T; Dallas DJ; Houghton A; Stringer B; Graham R; Russell G; Croucher PI
Biochem Biophys Res Commun; 1997 Jan; 230(2):335-9. PubMed ID: 9016778
[TBL] [Abstract][Full Text] [Related]
13. ADAM-10 over-expression increases cortical synaptogenesis.
Bell KF; Zheng L; Fahrenholz F; Cuello AC
Neurobiol Aging; 2008 Apr; 29(4):554-65. PubMed ID: 17187903
[TBL] [Abstract][Full Text] [Related]
14. Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas.
Dumas V; Kanitakis J; Charvat S; Euvrard S; Faure M; Claudy A
Anticancer Res; 1999; 19(4B):2929-38. PubMed ID: 10652575
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin K expression in basal cell carcinoma.
Ishida M; Kojima F; Okabe H
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e128-30. PubMed ID: 22220587
[TBL] [Abstract][Full Text] [Related]
16. Expression of CXCR4, MMP-13 and β-catenin in different histological subtypes of facial basal cell carcinoma.
Ciurea ME; Cernea D; Georgescu CC; Cotoi OS; Pătraşcu V; Pârvănescu H; Popa D; Pârvănescu V; Ciurea RN; Mercuţ R
Rom J Morphol Embryol; 2013; 54(4):939-51. PubMed ID: 24398989
[TBL] [Abstract][Full Text] [Related]
17. ADAM10 regulates proliferation, invasion, and chemoresistance of bladder cancer cells.
Fu L; Liu N; Han Y; Xie C; Li Q; Wang E
Tumour Biol; 2014 Sep; 35(9):9263-8. PubMed ID: 24935471
[TBL] [Abstract][Full Text] [Related]
18. Abundance of ADAM-8, -9, -10, -12, -15 and -17 and ADAMTS-1 in mouse uterus during the oestrous cycle.
Kim J; Kim H; Lee SJ; Choi YM; Lee SJ; Lee JY
Reprod Fertil Dev; 2005; 17(5):543-55. PubMed ID: 15907280
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
Poswar FO; Fraga CA; Farias LC; Feltenberger JD; Cruz VP; Santos SH; Silveira CM; de Paula AM; Guimarães AL
Pathol Res Pract; 2013 Nov; 209(11):705-9. PubMed ID: 24011615
[TBL] [Abstract][Full Text] [Related]
20. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer.
Pruessmeyer J; Ludwig A
Semin Cell Dev Biol; 2009 Apr; 20(2):164-74. PubMed ID: 18951988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
